ENDRA Life Sciences Statistics
Total Valuation
NDRA has a market cap or net worth of $6.88 million. The enterprise value is $6.48 million.
Important Dates
The last earnings date was Monday, November 17, 2025, before market open.
| Earnings Date | Nov 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NDRA has 1.17 million shares outstanding. The number of shares has increased by 841.75% in one year.
| Current Share Class | 1.17M |
| Shares Outstanding | 1.17M |
| Shares Change (YoY) | +841.75% |
| Shares Change (QoQ) | +6.15% |
| Owned by Insiders (%) | 6.08% |
| Owned by Institutions (%) | 1.80% |
| Float | 1.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 25.25 |
| P/TBV Ratio | 39.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 3.07.
| Current Ratio | 1.31 |
| Quick Ratio | 0.99 |
| Debt / Equity | 3.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -236.34% and return on invested capital (ROIC) is -136.15%.
| Return on Equity (ROE) | -236.34% |
| Return on Assets (ROA) | -101.97% |
| Return on Invested Capital (ROIC) | -136.15% |
| Return on Capital Employed (ROCE) | -725.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$381,295 |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.67% in the last 52 weeks. The beta is -0.33, so NDRA's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | +7.67% |
| 50-Day Moving Average | 5.85 |
| 200-Day Moving Average | 4.80 |
| Relative Strength Index (RSI) | 49.54 |
| Average Volume (20 Days) | 82,472 |
Short Selling Information
The latest short interest is 100,283, so 8.60% of the outstanding shares have been sold short.
| Short Interest | 100,283 |
| Short Previous Month | 89,024 |
| Short % of Shares Out | 8.60% |
| Short % of Float | 9.15% |
| Short Ratio (days to cover) | 1.07 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.44M |
| Pretax Income | -8.01M |
| Net Income | -8.01M |
| EBITDA | -8.39M |
| EBIT | -8.44M |
| Earnings Per Share (EPS) | -$12.43 |
Full Income Statement Balance Sheet
The company has $794,036 in cash and $525,328 in debt, giving a net cash position of $268,708 or $0.23 per share.
| Cash & Cash Equivalents | 794,036 |
| Total Debt | 525,328 |
| Net Cash | 268,708 |
| Net Cash Per Share | $0.23 |
| Equity (Book Value) | 171,380 |
| Book Value Per Share | 0.22 |
| Working Capital | 248,402 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$5.09 million and capital expenditures -$17,280, giving a free cash flow of -$5.10 million.
| Operating Cash Flow | -5.09M |
| Capital Expenditures | -17,280 |
| Free Cash Flow | -5.10M |
| FCF Per Share | -$4.38 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NDRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -841.75% |
| Shareholder Yield | -841.75% |
| Earnings Yield | -118.66% |
| FCF Yield | -75.64% |
Analyst Forecast
The average price target for NDRA is $38.00, which is 544.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 544.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 7, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Nov 7, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |